(Q46237102)

20 December 2017

title

N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants (English)

1 reference

20 December 2017

1 reference

patent ductus arteriosus

1 reference

P Nuntnarumit

1

0 references

author name string

A Khositseth

series ordinal

2

1 reference

20 December 2017

P Thanomsingh

series ordinal

3

1 reference

20 December 2017

publication date

20 November 2008

1 reference

20 December 2017

published in

Journal of Perinatology

1 reference

20 December 2017

volume

29

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

137-142

1 reference

20 December 2017

Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Treatment of patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

How good is clinical examination at detecting a significant patent ductus arteriosus in the preterm neonate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Essential biochemistry and physiology of (NT-pro)BNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Clinical value of NT-ProBNP and BNP in pediatric cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Use of NT-proBNP in routine testing and comparison to BNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Normal values of B type natriuretic peptide in infants, children, and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Severity of the ductal shunt: a comparison of different markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Cardiac troponin T and N-terminal-pro-B type natriuretic peptide reflect myocardial function in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

Patent ductus arteriosus in neonates with severe respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

Indomethacin for asymptomatic patent ductus arteriosus in preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP)

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

Sensitivity, specificity and predictive value of clinical findings, m-mode echocardiography and continuous-wave Doppler sonography in the diagnosis of symptomatic patent ductus arteriosus in preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.185

7 January 2021

Identifiers

DOI

10.1038/JP.2008.185

1 reference

20 December 2017

Dimensions Publication ID

1049203101

0 references

1 reference

20 December 2017